The MHRA has approved Siiltibcy, a new skin test that uses recombinant proteins to more accurately detect tuberculosis in ...

Over the last decade, there's been growing evidence that people can have TB without having any symptoms. But there is still much uncertainty over how such asymptomatic TB functions in the body and how ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine ...

There's a global shortage of radiologists. Now artificial intelligence is helping speed up the diagnosis of tuberculosis in ...

How one woman went from a severe alopecia areata diagnosis to finding the right prescription treatment for her—and getting ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world's deadliest infectious disease.

A 20-year-old from Bizana, Eastern Cape, endured two years of TB treatment while lymphoma spread unchecked. Misdiagnosed at a ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive ...

Oxford Nanopore Technologies plc and Biomérieux SA launched Ampore-TB, a research use only test that can rapidly detect mutations linked to antimicrobial resistance in tuberculosis. With ...

The test, a decade in the making, is being touted by UCSD physicians as addressing "a critical diagnostic gap, providing ...